
MedDay appoints senior head from Sanofi
pharmafile | January 16, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Philippe Goupit, Sanofi, medday
Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director.
Goupit was until recently the vice president of Sanofi’s corporate licenses unit, and will be taking to MedDay significant business and development experience covering the biotech and pharma sector.
Goupit has more than 30 years’ experience in the industry, spending over 20 of those at Sanofi. His work in business development covers M&A – as a former head of the corporate M&A group in Sanofi – and licensing activities. He also served for some years as the head of investor relations at the French firm.
Frédéric Sedel who is the chief executive of MedDay, says: “Philippe’s broad experience will be hugely beneficial to MedDay as the company continues to develop its pipeline of assets which address areas of unmet need in neurological and psychiatric diseases, through brain metabolism. Through his experience Philippe will contribute to MedDay’s corporate and business development strategy.”
Goupit adds: “I am delighted to be joining the board of MedDay to help it in the next steps of its corporate development.”
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






